Epilepsy
📧 Sign up to get email alerts when something new happens for Epilepsy.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-10-27FDA Approved: ACETAZOLAMIDE — Original Application (Chartwell RX, LLC)
FDA approved an original application for acetazolamide from Chartwell RX, LLC.
-
FDA approval · 2016-10-26FDA Approved: KEPPRA — Supplemental Application (UCB, Inc.)
FDA approved a supplemental application for KEPPRA (levetiracetam) submitted by UCB, Inc. This action updates the drug's labeling related to…
-
FDA approval · 2016-10-26FDA Approved: KEPPRA XR — Supplemental Application (UCB, Inc.)
The FDA approved KEPPRA XR (extended-release levetiracetam) via a supplemental application from UCB, adding an extended-release formulation …
-
FDA approval · 2016-10-26FDA Approved: FYCOMPA — Supplemental Application (Eisai Inc.)
FDA approved Eisai Inc.'s supplemental application for FYCOMPA (perampanel). This action approves a supplemental indication/labeling change …
-
CLINICAL_TRIALS trial_result · 2016-10-25Clinical Trial Update: Assess Specific Kinds of Children Challenges for Neurologic Devices Study
A pediatric neurologic devices trial (NCT01191307) evaluating specific challenges in children with dystonia and epilepsy was terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-10-18Clinical Trial Update: Cardiac Rhythm Abnormalities in Patients With Refractory Epilepsy at High Risk for Sudden Death
A completed trial update examining cardiac rhythm abnormalities in patients with epilepsy who are at high risk for sudden death.
-
EMA safety_alert · 2016-10-14EMA recommends measures to ensure safe use of Keppra oral solution
EMA recommends measures to ensure safe use of Keppra (levetiracetam) oral solution, addressing dosing and administration risks.
-
CLINICAL_TRIALS trial_result · 2016-10-12Clinical Trial Update: EEG-fMRI: Towards a Useful Clinical Tool in Epilepsy
A completed University of Birmingham study evaluated the potential of EEG-fMRI as a clinical tool for epilepsy.
-
CLINICAL_TRIALS research · 2016-10-12Clinical Trial Update: Clinical Trial of Vagus Nerve Stimulation for Treatment of Refractory Epilepsy [EARLY_Phase 1]
Update on an early-phase clinical trial evaluating vagus nerve stimulation for refractory epilepsy.
-
CLINICAL_TRIALS trial_result · 2016-10-07Clinical Trial Update: Lactate Compared to Creatine Kinase as Diagnostic Marker in Generalized Epileptic Seizure
A completed clinical trial evaluated lactate as a diagnostic biomarker compared with creatine kinase for generalized epileptic seizures, inf…
-
CLINICAL_TRIALS trial_result · 2016-10-05Clinical Trial Update: Efficacy of Fluoxetine Against Seizure-induced Central Apneas [Phase 3]
Phase 3 trial assessing fluoxetine for reducing seizure-induced central apneas in epilepsy has completed.
-
CLINICAL_TRIALS trial_result · 2016-09-29Clinical Trial Update: Efficacy and Safety of Eslicarbazepine Acetate as Monotherapy for Patients With Newly Diagnosed Partial-onset Seizures [Phase 3]
Efficacy and safety results from a Phase 3 trial evaluating eslicarbazepine acetate as monotherapy in adults with newly diagnosed partial-on…
-
CLINICAL_TRIALS trial_result · 2016-09-23Clinical Trial Update: Patients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice Versa [Phase 3]
A Phase 3 study evaluated switching between Lamictal immediate-release and extended-release formulations in people with epilepsy. The trial …
-
CLINICAL_TRIALS trial_result · 2016-09-23Clinical Trial Update: Everolimus (RAD001) Therapy for Epilepsy in Patients With Tuberous Sclerosis Complex (TSC) [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluated everolimus for epilepsy in patients with tuberous sclerosis complex; results were posted in 2…
-
FDA approval · 2016-09-19FDA Approved: LAMOTRIGINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for lamotrigine from Aurobindo Pharma Limited.
-
FDA approval · 2016-09-16FDA Approved: LEVETIRACETAM — Original Application (Mylan Institutional LLC)
FDA approved an original ANDA for levetiracetam from Mylan Institutional LLC, enabling a generic version of the anticonvulsant to reach the …
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Pediatric Epilepsy Trial in Subjects 1-24 Months [Phase 2]
Phase 2 pediatric epilepsy trial in children aged 1-24 months sponsored by GlaxoSmithKline has completed.
-
CLINICAL_TRIALS trial_result · 2016-09-08Clinical Trial Update: Feasibility of Mini-EEG in the Prehospital Setting
A completed feasibility study evaluating the use of a Mini-EEG device in the prehospital setting for patients with epilepsy or coma.
-
CLINICAL_TRIALS trial_result · 2016-09-07Clinical Trial Update: Effect of Three Different Doses of Oral Cholecalciferol on 25-Hydroxyvitamin D Changes Among Epilepsy Patients With Hypovitaminosis D [Phase 4]
A Phase 4 trial compared three oral doses of cholecalciferol (vitamin D3) and assessed changes in 25-hydroxyvitamin D in epilepsy patients w…
-
CLINICAL_TRIALS trial_result · 2016-09-02Clinical Trial Update: UCB Antiepileptic Drugs (AED) Pregnancy Registry (Formerly the Keppra® Pregnancy Registry)
Completed UCB-sponsored antiepileptic drugs pregnancy registry (formerly Keppra Pregnancy Registry) evaluating pregnancy outcomes such as bi…
-
FDA approval · 2016-09-02FDA Approved: LAMOTRIGINE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for lamotrigine from Alembic Pharmaceuticals Limited under an ANDA. This action represents a minor r…
-
CLINICAL_TRIALS trial_result · 2016-08-31Clinical Trial Update: Methylphenidate Treatment of Attention Deficits in Epilepsy [Phase 4]
This update reports results from a Phase 4 trial evaluating methylphenidate for attention deficits in people with epilepsy; the study is com…
-
CLINICAL_TRIALS research · 2016-08-31Clinical Trial Update: Interest Balance Auto-immune Population in Patients With Focal Epilepsy of Unknown Cause, Not Structural, Not Genetics, Newly Diagnosed [NA]
A clinical trial update describing a study on autoimmune involvement in newly diagnosed focal epilepsy of unknown cause (not structural or g…
-
CLINICAL_TRIALS trial_result · 2016-08-24Clinical Trial Update: Retrospective Evaluation of Perampanel in a French Neurology and Epileptology Department (Hospices Civil de Lyon)
A retrospective evaluation of perampanel use in patients with refractory epilepsy at a French neurology and epileptology department summariz…
-
CLINICAL_TRIALS trial_result · 2016-08-16Clinical Trial Update: Efficacy and Safety of Diazepam in the Management of Refractory Epilepsy in Selected Patients Who Require Intermittent Medical Intervention for Acute Repetitive Seizures. [Phase 3]
Phase 3 trial evaluating diazepam for management of refractory epilepsy in patients requiring intermittent medical intervention for acute re…